EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study

Noémie de Cacqueray iD, Mehdi Oualha iD, Frantz Foissac iD, Leo Froelicher Bournaud, Gabrielle Lui iD, Emmanuelle Bille, Christophe Chardot, Carmen Capito iD, Florence Lacaille, Philippine Widmer, Julie Toubiana, Jean Marc Tréluyer und 3 weitere

Clinical Pharmacology & Therapeutics · 2026-08 · 120 (2) · 484-491

DOI: 10.1002/cpt.70346 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 29.05.2026. Verfasst von Noémie de Cacqueray und 14 weiteren Autor:innen. Beteiligte Einrichtung: Service Réanimation et Soins Intensifs Polyvalents Pédiatriques - SMUR pédiatrique, AP-HP, Hôpital Necker Enfants Malades, Paris, France. Hauptthemen laut MEDLINE: Liver Transplantation, Ascitic Fluid, Anti-Bacterial Agents, Models, Biological. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Piperacillin–tazobactam is frequently used in children undergoing liver transplantation (LT), yet its pharmacokinetics (PK) in this population remains poorly characterized. We aimed to develop a population pharmacokinetic model for piperacillin in plasma and peritoneal fluid in children undergoing LT and to optimize dosing regimen for this population. We conducted a retrospective, single‐center, observational study including all children receiving piperacillin–tazobactam as prophylaxis for LT and had at least one piperacillin concentration in both plasma and peritoneal fluid. PK analysis was conducted using nonlinear mixed effect modeling (Monolix) and was part of Optimome study. We included 31 patients with a median (range) age of 4 years (4 months–17 years). A total of 172 plasma and 146 peritoneal fluid samples were analyzed. Plasma concentrations were best fitted by a one‐compartment model with first‐order elimination. A virtual effect site compartment was added to adequately describe piperacillin concentrations in plasma and peritoneal fluid. Allometrically scaled body weight (pre‐transplant and current values) and glomerular filtration rate (eGFR) were identified as significant covariates. Median (range) peritoneal/plasma AUC 0–24h ratio was 72 (45–94) %. Simulations showed that optimal dosing regimens ranged from 300 mg/kg/day (q6h over 3 hours) to 400 mg/kg/day as a continuous infusion, depending on the PK target (i.e., f T >1 × MIC or f T >4 × MIC ) and patient eGFR. In children undergoing LT, body weight and renal function explained some of the between subject variability for piperacillin PK. Higher dosing regimen combined with therapeutic drug monitoring is necessary to optimize exposure in plasma and at surgical site.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationAscitic FluidAnti-Bacterial AgentsModels, BiologicalPiperacillinPiperacillin, Tazobactam Drug CombinationHumansChild, PreschoolChildMaleFemaleRetrospective StudiesInfantAdolescentArea Under CurveAntibiotic Prophylaxis

Substanzen

Anti-Bacterial AgentsPiperacillinPiperacillin, Tazobactam Drug Combination

Autor:innen und Institutionen

  • Service Réanimation et Soins Intensifs Polyvalents Pédiatriques - SMUR pédiatrique, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
  • Université Paris Cité, Inserm, UMR1343, Pharmacologie et Évaluations des Thérapeutiques Chez l'Enfant et la Femme Enceinte, Paris, France.
  • Service Pharmacologie clinique, AP-HP, Hôpital Cochin, Paris, France.
  • Service Microbiologie, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
  • Service Chirurgie pédiatrique, Transplantation, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
  • Service Gastroentérologie-Nutrition pédiatriques et Unité d'Hépatologie Transplantation Pédiatrique, AP-HP, Hôpital Necker Enfants Malades, Paris, France.

ORCID-Profile: Noémie de Cacqueray, Mehdi Oualha, Frantz Foissac, Gabrielle Lui, Carmen Capito, Agathe Béranger

Zitieren

APA

de Cacqueray, N., Oualha, M., Foissac, F., Bournaud, L. F., Lui, G., Bille, E., Chardot, C., Capito, C., Lacaille, F., Widmer, P., Toubiana, J., Tréluyer, J. M., Benaboud, S., Bouazza, N., & Béranger, A. (2026). Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study. Clinical Pharmacology & Therapeutics, 120(2), 484-491. https://doi.org/10.1002/cpt.70346

Vancouver

de Cacqueray N, Oualha M, Foissac F, Bournaud LF, Lui G, Bille E, et al. Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study. Clinical Pharmacology & Therapeutics. 2026;120(2):484-491. doi:10.1002/cpt.70346

BibTeX
@article{deCacqueray2026,
  author = {de Cacqueray, Noémie and Oualha, Mehdi and Foissac, Frantz and Bournaud, Leo Froelicher and Lui, Gabrielle and Bille, Emmanuelle and Chardot, Christophe and Capito, Carmen and Lacaille, Florence and Widmer, Philippine and Toubiana, Julie and Tréluyer, Jean Marc and Benaboud, Sihem and Bouazza, Naïm and Béranger, Agathe},
  title = {Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  volume = {120},
  number = {2},
  pages = {484--491},
  doi = {10.1002/cpt.70346}
}
Kostenlos starten →